Stephen G. Oxberry
Short-term opioids for breathlessness in stable chronic heart failure: A randomized controlled trial
Oxberry, Stephen G.; Torgerson, David J.; Bland, J. Martin; Clark, Andrew L.; Cleland, John G. F.; Johnson, Miriam J.
Authors
David J. Torgerson
J. Martin Bland
Andrew L. Clark
John G. F. Cleland
Professor Miriam Johnson Miriam.Johnson@hull.ac.uk
Professor
Abstract
Aims To assess the effect of oral opioids vs. placebo on breathlessness in patients with chronic heart failure (CHF). Methods and results Oral morphine (Oramorph), oral oxycodone (Oxynorm), and placebo were studied in an outpatient setting. Once randomized, participants received all three interventions in a controlled double-blind crossover trial for 4 days each, with a 3-day washout between interventions. Patients known to the Hull and East Yorkshire Academic Cardiology department with CHF (New York Heart Association Grade III–IV) were invited to participate. Participants were eligible if they were on standard medical therapy with angiotensin-converting enzyme inhibitors/angiotensin receptor blockers, and diuretics. Participant-rated change in 11-point numerical rating scale (NRS) (average over previous 24 h) breathlessness severity score from baseline (Day 1) to Day 4 of treatment was the primary outcome measure. The study was powered to detect a one-point change in severity.Thirty-nine patients were randomized and 35 completed all three study arms. Breathlessness severity was reduced from baseline with all three interventions. There was no statistically significant difference between active intervention and placebo or between the two types of opioid for the primary endpoint [-1.37 in NRS score for placebo group vs. -0.41 in morphine group (P = 0.13) and -1.29 for oxycodone group (P = 0.90)]. The response to treatment was not affected by aetiology, severity of CHF, or concurrent drug therapy. Opioid administration did not cause detrimental changes in clinical observations and was well tolerated. Conclusion We demonstrated no benefit over placebo for the relief of breathlessness with short-term low-dose oral opioids for CHF patients.
Citation
Oxberry, S. G., Torgerson, D. J., Bland, J. M., Clark, A. L., Cleland, J. G. F., & Johnson, M. J. (2011). Short-term opioids for breathlessness in stable chronic heart failure: A randomized controlled trial. European journal of heart failure, 13(9), 1006-1012. https://doi.org/10.1093/eurjhf/hfr068
Journal Article Type | Article |
---|---|
Acceptance Date | Apr 15, 2011 |
Online Publication Date | Feb 18, 2014 |
Publication Date | Sep 1, 2011 |
Deposit Date | Nov 13, 2014 |
Journal | European Journal Of Heart Failure |
Print ISSN | 1388-9842 |
Electronic ISSN | 1879-0844 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 13 |
Issue | 9 |
Pages | 1006-1012 |
DOI | https://doi.org/10.1093/eurjhf/hfr068 |
Keywords | Cardiology and Cardiovascular Medicine |
Public URL | https://hull-repository.worktribe.com/output/467377 |
Contract Date | Nov 13, 2014 |
You might also like
Chronobiology in breathlessness across 24 hours in people with persistent breathlessness
(2024)
Journal Article
Hospital admissions in the last year of life of patients with heart failure
(2024)
Journal Article
Downloadable Citations
About Repository@Hull
Administrator e-mail: repository@hull.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search